Remission in rheumatoid arthritis: missing objectives by using inadequate DAS28 targets
D Aletaha, JS Smolen - Nature Reviews Rheumatology, 2019 - nature.com
D Aletaha, JS Smolen
Nature Reviews Rheumatology, 2019•nature.comRemission in rheumatoid arthritis: missing objectives by using inadequate DAS28 targets |
Nature Reviews Rheumatology Skip to main content Thank you for visiting nature.com. You are
using a browser version with limited support for CSS. To obtain the best experience, we
recommend you use a more up to date browser (or turn off compatibility mode in Internet
Explorer). In the meantime, to ensure continued support, we are displaying the site without
styles and JavaScript. Advertisement Nature Reviews Rheumatology View all journals Search …
Nature Reviews Rheumatology Skip to main content Thank you for visiting nature.com. You are
using a browser version with limited support for CSS. To obtain the best experience, we
recommend you use a more up to date browser (or turn off compatibility mode in Internet
Explorer). In the meantime, to ensure continued support, we are displaying the site without
styles and JavaScript. Advertisement Nature Reviews Rheumatology View all journals Search …
For too long, the definition of ‘remission’ in rheumatoid arthritis has been distorted by the widespread use of an inadequate tool, with consequences for clinical care and for making sense of clinical trial data. Has the time come to move away from DAS28-defined remission?
nature.com
